{
    "additionDate": "2021-01-18T09:28:47Z",
    "bioagentsCURIE": "bioagents:aidrug2cov",
    "bioagentsID": "aidrug2cov",
    "collectionID": [
        "COVID-19"
    ],
    "confidence_flag": "agent",
    "description": "AIdrug2cov is a network representation learning-based methodology to discover drug mechanism and anti-inflammatory response for patients with COVID-19.",
    "editPermission": {
        "type": "private"
    },
    "homepage": "https://github.com/pengsl-lab/AIdrug2cov",
    "language": [
        "Python"
    ],
    "lastUpdate": "2021-01-21T15:25:32Z",
    "name": "AIdrug2cov",
    "owner": "Kigaard",
    "publication": [
        {
            "doi": "10.26434/CHEMRXIV.12531314.V2"
        }
    ],
    "agentType": [
        "Script"
    ],
    "topic": [
        {
            "term": "Allergy, clinical immunology and immunotherapeutics",
            "uri": "http://edamontology.org/topic_3400"
        },
        {
            "term": "Drug development",
            "uri": "http://edamontology.org/topic_3373"
        },
        {
            "term": "Drug discovery",
            "uri": "http://edamontology.org/topic_3336"
        },
        {
            "term": "Pharmacology",
            "uri": "http://edamontology.org/topic_0202"
        },
        {
            "term": "Preclinical and clinical studies",
            "uri": "http://edamontology.org/topic_3379"
        }
    ],
    "validated": 1
}
